| 英文名 | (3R,4S,5S,6R)-5-Methoxy-4-[(2R,3R)-2-methyl-3-(3-methyl-2-buten-1-yl)-2-oxiranyl]-1-oxaspiro[2.5]oct-6-yl 6-(2,2-difluoroethyl)-2,6-diazaspiro[3.3]heptane-2-carboxylate |
|---|---|
| 英文别名 |
(3R,4S,5S,6R)-5-Methoxy-4-[(2R,3R)-2-methyl-3-(3-methyl-2-buten-1-yl)-2-oxiranyl]-1-oxaspiro[2.5]oct-6-yl 6-(2,2-difluoroethyl)-2,6-diazaspiro[3.3]heptane-2-carboxylate
2,6-Diazaspiro[3.3]heptane-2-carboxylic acid, 6-(2,2-difluoroethyl)-, (3R,4S,5S,6R)-5-methoxy-4-[(2R,3R)-2-methyl-3-(3-methyl-2-buten-1-yl)oxiranyl]-1-oxaspiro[2.5]oct-6-yl ester |
| 描述 | Relzomostat是一种甲硫氨酸氨基肽酶2(MetAP2)抑制剂。Relzomostat可用于肥胖、2型糖尿病和其他肥胖相关疾病的研究[1]。 |
|---|---|
| 相关类别 | |
| 参考文献 |
| 密度 | 1.3±0.1 g/cm3 |
|---|---|
| 沸点 | 535.4±50.0 °C at 760 mmHg |
| 分子式 | C24H36F2N2O5 |
| 分子量 | 470.55 |
| 闪点 | 277.6±30.1 °C |
| 精确质量 | 470.259216 |
| LogP | 2.19 |
| 蒸汽压 | 0.0±1.4 mmHg at 25°C |
| 折射率 | 1.550 |